Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platform randomised trial of treatments for COVID-19 in general practice
2022-501559-99-00Phase 4Completed
- Sponsor
- Maastricht University
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of montelukast in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Maastricht University. Primary endpoint: Time to recovery within 28 days. Started Mar 2023; status: completed.
02
Drugs
montelukast
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2022-501559-99-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501559-99-00.